Argenx U.S. FDA , Efgartigimod , Pharmanews , Biopharmaceutical, Company, Generalized Myasthenia Gravis , FDA Approval by admin December 19, 2021 written by admin December 19, 2021 0 comment Share 0 FacebookTwitterPinterestEmail admin Leave a Comment Cancel ReplyYou must be logged in to post a comment. This site uses Akismet to reduce spam. Learn how your comment data is processed.